Skip to Content

T. Rowe Price Health Sciences I THISX Fund Analysis

| Medalist Rating as of | See T. Rowe Price Investment Hub

Morningstar’s Analysis THISX

Will THISX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A good bet in the healthcare sector.

Senior Analyst Adam Sabban

Adam Sabban

Senior Analyst


T. Rowe Price Health Sciences earns a Morningstar Analyst Rating of Silver because of its capable, well-resourced team and strong investment process parameters.

Rated on Published on

Unlock our full analysis with Morningstar Investor